Free Trial

ATB Cormark Capital Markets Issues Pessimistic Forecast for Kits Eyecare (TSE:KITS) Stock Price

Key Points

  • ATB Cormark lowered its price target for Kits Eyecare from C$20.00 to C$16.75 while maintaining a "speculative buy" rating, implying about a 46.5% upside from the current price.
  • KITS shares fell C$0.95 to C$11.43 on heavy volume (306,356 shares vs. a 115,911 average), with a market cap of C$388.5M, a P/E of 127, and a 1‑year range of C$11.12–C$22.56.
  • In the most recent quarter the company reported EPS of C$0.06 on revenue of C$57.47M; Kits Eyecare describes itself as a fast‑growing, vertically integrated digital eyecare provider with in‑house lens manufacturing and an AI‑driven fit experience.
  • Five stocks to consider instead of Kits Eyecare.

Kits Eyecare (TSE:KITS - Get Free Report) had its price objective decreased by research analysts at ATB Cormark Capital Markets from C$20.00 to C$16.75 in a research note issued to investors on Thursday,BayStreet.CA reports. The firm currently has a "speculative buy" rating on the stock. ATB Cormark Capital Markets' price objective indicates a potential upside of 46.54% from the company's current price.

Kits Eyecare Stock Performance

Shares of KITS stock traded down C$0.95 during trading on Thursday, reaching C$11.43. The company's stock had a trading volume of 306,356 shares, compared to its average volume of 115,911. The stock has a market capitalization of C$388.51 million, a P/E ratio of 127.00 and a beta of 0.46. Kits Eyecare has a 1-year low of C$11.12 and a 1-year high of C$22.56.

Kits Eyecare (TSE:KITS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$57.47 million during the quarter.

Kits Eyecare Company Profile

(Get Free Report)

KITS TSX: KITS is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kits Eyecare Right Now?

Before you consider Kits Eyecare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kits Eyecare wasn't on the list.

While Kits Eyecare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines